Barriers and Facilitating Factors of Adherence to Antidepressant Treatments: An Exploratory Qualitative Study with Patients and Psychiatrists

Beatriz González de León, Analía Abt-Sacks, Francisco Javier Acosta Artiles, Tasmania del Pino-Sedeño, Vanesa Ramos-García, Cristobalina Rodríguez Álvarez, Daniel Bejarano-Quisoboni and María M. Trujillo-Martín ()
Additional contact information
Beatriz González de León: Multiprofessional Teaching Unit of Family and Community Care La Laguna-Tenerife Norte, Management of Primary Care of Tenerife, 38320 Santa Cruz de Tenerife, Spain
Analía Abt-Sacks: Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de Tenerife, Spain
Francisco Javier Acosta Artiles: Department of Mental Health, General Management of Healthcare Programs, Canary Islands Health Service, 35071 Las Palmas de Gran Canaria, Spain
Tasmania del Pino-Sedeño: Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de Tenerife, Spain
Vanesa Ramos-García: Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de Tenerife, Spain
Cristobalina Rodríguez Álvarez: Department of Preventive Medicine and Public Health, University of La Laguna, 38071 Santa Cruz de Tenerife, Spain
Daniel Bejarano-Quisoboni: Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III Health Institute, 28029 Madrid, Spain
María M. Trujillo-Martín: Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de Tenerife, Spain

IJERPH, 2022, vol. 19, issue 24, 1-26

Abstract: This study examines the experiences and expectations of patients with depressive disorders regarding the disease and different antidepressants, as well as examining the barriers and facilitating factors that could affect their adherence to medications. An exploratory qualitative study was carried out. The study involved two focus groups made up of patients and caregivers and six semi-structured interviews with psychiatrists. In both cases, the participants were selected by intentional theoretical sampling, seeking maximum significance variation of social types. Prejudice about the side effects of medication was relevant. The importance of patients being well informed about the disease/treatments was noteworthy. The stigmatization of antidepressants by patients was identified as a barrier to medication adherence. The involvement of family members and the motivation of patients to be actively involved in the process to recover from the disease were identified as facilitating factors. The work carried out suggests the need for patients to have rigorous information about the disease/treatment to reduce the possible prejudices generated by beliefs. Maintaining greater contact and monitoring of patients/caregivers to help therapeutic adherence in patients with depressive disorders was also identified as being of great importance.

Keywords: medication adherence; depressive disorders; antidepressants; qualitative research (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/24/16788/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/24/16788/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:24:p:16788-:d:1003300

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().